Therefore, on the premise of ensuring that the expression level of FoxO1 is consistent, we explored whether GLP-1 (7-36) could regulate DHEA-induced PCOS ovarian MGCs proliferation and apoptosis by modifying FoxO1 phosphorylation site. The gene discussed is FOXO1; the disease is polycystic ovary syndrome.